A detailed history of Johnson Financial Group, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 47 shares of BIIB stock, worth $7,003. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47
Previous 39 20.51%
Holding current value
$7,003
Previous $9,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$189.07 - $236.8 $1,512 - $1,894
8 Added 20.51%
47 $9,000
Q1 2024

May 14, 2024

SELL
$212.02 - $267.71 $9,752 - $12,314
-46 Reduced 54.12%
39 $8,000
Q4 2023

Feb 09, 2024

BUY
$222.59 - $267.94 $6,232 - $7,502
28 Added 49.12%
85 $21,000
Q3 2023

Nov 14, 2023

BUY
$253.3 - $285.89 $14,438 - $16,295
57 New
57 $14,000
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $19,257 - $24,748
-86 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$282.99 - $369.05 $233,466 - $304,466
-825 Reduced 90.56%
86 $24,000
Q2 2021

Aug 13, 2021

BUY
$259.0 - $414.71 $44,548 - $71,330
172 Added 23.27%
911 $315,000
Q1 2021

May 14, 2021

BUY
$242.95 - $284.63 $54,420 - $63,757
224 Added 43.5%
739 $207,000
Q4 2020

Feb 12, 2021

SELL
$236.26 - $355.63 $75,130 - $113,090
-318 Reduced 38.18%
515 $126,000
Q3 2020

Nov 12, 2020

BUY
$264.77 - $305.71 $16,945 - $19,565
64 Added 8.32%
833 $236,000
Q2 2020

Aug 11, 2020

BUY
$258.66 - $342.55 $10,346 - $13,702
40 Added 5.49%
769 $206,000
Q1 2020

May 14, 2020

BUY
$268.85 - $341.04 $6,452 - $8,184
24 Added 3.4%
729 $231,000
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $44,672 - $61,726
-203 Reduced 22.36%
705 $209,000
Q3 2019

Nov 12, 2019

BUY
$217.44 - $243.88 $22,831 - $25,607
105 Added 13.08%
908 $211,000
Q2 2019

Aug 09, 2019

BUY
$219.29 - $241.72 $11,183 - $12,327
51 Added 6.78%
803 $188,000
Q1 2019

May 13, 2019

BUY
$216.71 - $338.96 $13,869 - $21,693
64 Added 9.3%
752 $178,000
Q4 2018

Feb 11, 2019

BUY
$278.5 - $352.75 $114,185 - $144,627
410 Added 147.48%
688 $207,000
Q3 2018

Nov 09, 2018

BUY
$293.51 - $383.83 $4,989 - $6,525
17 Added 6.51%
278 $98,000
Q2 2018

Aug 07, 2018

SELL
$257.52 - $306.91 $11,588 - $13,810
-45 Reduced 14.71%
261 $76,000
Q1 2018

May 07, 2018

SELL
$260.13 - $367.91 $399,039 - $564,373
-1,534 Reduced 83.37%
306 $84,000
Q4 2017

Feb 12, 2018

SELL
$307.64 - $344.58 $35,378 - $39,626
-115 Reduced 5.88%
1,840 $586,000
Q3 2017

Nov 09, 2017

BUY
$281.15 - $329.69 $549,648 - $644,543
1,955
1,955 $612,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Johnson Financial Group, Inc. Portfolio

Follow Johnson Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Johnson Financial Group, Inc. with notifications on news.